544312 HAMPS

Hamps Bio Share Price

 

 

Start SIP in HAMPS

Start SIP

Performance

  • Low
  • ₹18
  • High
  • ₹19
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹38
  • Open Price₹19
  • Previous Close₹19
  • Volume28,000
  • 50 DMA₹22.08
  • 100 DMA₹23.85
  • 200 DMA-

Investment Returns

  • Over 1 Month -18.9%
  • Over 3 Month -11.9%
  • Over 6 Month -3.14%
  • Over 1 Year -46.38%

Smart Investing Starts Here Start SIP with Hamps Bio for Steady Growth!

Invest Now

Hamps Bio Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 54.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 16
  • P/B Ratio
  • 1.9
  • Average True Range
  • 0.97
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.07
  • RSI
  • 39.31
  • MFI
  • 57.09

Hamps Bio Financials

Hamps Bio Technicals

EMA & SMA

Current Price
₹18.50
0 (0%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 0
  • 20 Day
  • ₹20.42
  • 50 Day
  • ₹22.08
  • 100 Day
  • ₹23.85
  • 200 Day
  • -

Resistance and Support

18.58 Pivot Speed
  • R3 20.17
  • R2 19.58
  • R1 19.17
  • S1 18.17
  • S2 17.58
  • S3 17.17

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Hamps Bio Ltd. specializes in Pharmaceutical Formulation and Freeze-Dried Ingredients with two core divisions. Operating across Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh, it serves B2B and B2C markets with therapeutic medicines and innovative freeze-dried food products.

Hamps Bio Ltd has an operating revenue of Rs. 17.14 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 6% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 38 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 158 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Hamps Bio Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Half Yearly Results (Revised) issue of equity shares in the ratio of 1:1 of Rs. 10/-.
2025-07-29 Bonus issue
2025-05-28 Audited Results
Date Purpose Remarks
2025-09-09 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Hamps Bio F&O

Hamps Bio Shareholding Pattern

71.99%
0%
24.06%
3.95%

About Hamps Bio

  • NSE Symbol
  • HAMPS
  • BSE Symbol
  • 544312
  • Chairman & Managing Director
  • Mr. Herrik Mountbaton Shah
  • ISIN
  • INE0QBD01018

Similar Stocks to Hamps Bio

Hamps Bio FAQs

Hamps Bio share price is ₹18 As on 12 January, 2026 | 20:31

The Market Cap of Hamps Bio is ₹16.1 Cr As on 12 January, 2026 | 20:31

The P/E ratio of Hamps Bio is 54.1 As on 12 January, 2026 | 20:31

The PB ratio of Hamps Bio is 1.9 As on 12 January, 2026 | 20:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23